The University of Southampton
University of Southampton Institutional Repository

Natural killer cells in anti-tumour immunity

Natural killer cells in anti-tumour immunity
Natural killer cells in anti-tumour immunity
Natural killer (NK) cells are innate lymphocytes that have an important role in anti-tumour immunity. NK cells directly lyse tumour cells and can modulate the wider immune system via cytokine and chemokine production. Regulation of NK cell function against cancer is mediated by the balance of activating and inhibitory signals transmitted through a plethora of germline-encoded non-rearranged cell surface receptors. In cancer patients, NK cells can become dysfunctional due to immunosuppressive factors within the tumour microenvironment (TME). Therapeutic strategies to boost NK cell activation against cancer and overcome immunosuppression are under intense development. In this article, we outline the regulation of NK cell function against cancer, the evidence for the control of cancer by NK cells and mechanisms by which NK cells are inhibited within the TME. Finally, we discuss recent therapeutic approaches targeting NK cells that offer the promise of improved anti-tumour responses.
Elsevier
Graham, Lara V.
4a7bbe46-4e8e-476d-87f5-5c83304a5293
Blunt, Matthew D.
b1109de3-6045-4bc3-bd77-6cf26504697d
Graham, Lara V.
4a7bbe46-4e8e-476d-87f5-5c83304a5293
Blunt, Matthew D.
b1109de3-6045-4bc3-bd77-6cf26504697d

Graham, Lara V. and Blunt, Matthew D. (2024) Natural killer cells in anti-tumour immunity. In, Reference Module in Life Sciences. Elsevier. (doi:10.1016/b978-0-128-24465-4.00060-0).

Record type: Book Section

Abstract

Natural killer (NK) cells are innate lymphocytes that have an important role in anti-tumour immunity. NK cells directly lyse tumour cells and can modulate the wider immune system via cytokine and chemokine production. Regulation of NK cell function against cancer is mediated by the balance of activating and inhibitory signals transmitted through a plethora of germline-encoded non-rearranged cell surface receptors. In cancer patients, NK cells can become dysfunctional due to immunosuppressive factors within the tumour microenvironment (TME). Therapeutic strategies to boost NK cell activation against cancer and overcome immunosuppression are under intense development. In this article, we outline the regulation of NK cell function against cancer, the evidence for the control of cancer by NK cells and mechanisms by which NK cells are inhibited within the TME. Finally, we discuss recent therapeutic approaches targeting NK cells that offer the promise of improved anti-tumour responses.

This record has no associated files available for download.

More information

e-pub ahead of print date: 20 October 2024

Identifiers

Local EPrints ID: 503970
URI: http://eprints.soton.ac.uk/id/eprint/503970
PURE UUID: eb4e23c0-17cf-422c-b6e3-7ecb50204e33
ORCID for Lara V. Graham: ORCID iD orcid.org/0009-0006-5420-9020
ORCID for Matthew D. Blunt: ORCID iD orcid.org/0000-0003-1099-3985

Catalogue record

Date deposited: 19 Aug 2025 17:04
Last modified: 23 Aug 2025 02:22

Export record

Altmetrics

Contributors

Author: Lara V. Graham ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×